By Mr Christopher Steer

Preprints

Rebello RJ; Posner A; Dong R; Prall OWJ; Sivakumaran T; Mitchell CB; Flynn A; Caneborg A; Mitchell C; Kanwal S; Fedele C; Webb S; Fisher K; Wong H-L; Balachander S; Zhu W; Nicolson S; Dimitriadis V; Wilcken N; DeFazio A; Gao B; Singh M; Collins I; Steer C; Warren M; Karanth N; Xu H; Fellowes A; Hicks RJ; Stewart KP; Shale C; Priestley P; Dawson S-J; Vissers JHA; Fox SB; Schofield P; Bowtell D; Hofmann O; Grimmond SM; Mileshkin L; Tothill RW, 2024, Whole genome sequencing improves tissue of origin diagnosis and treatment options for cancer of unknown primary, http://dx.doi.org/10.1101/2024.08.09.24311642

Tuesley KM; Spilsbury K; Webb PM; Protani MM; Dixon-Suen S; Pearson S-A; Donovan P; Coory M; Steer CB; Stewart LM; Pandeya N; Jordan SJ, 2023, Association between Antihypertensive Medicine Use and Risk of Ovarian Cancer in Women Aged 50 Years and Older, http://dx.doi.org/10.2139/ssrn.4414764

Posner A; Prall OWJ; Sivakumaran T; Etemadamoghadam D; Thio N; Pattison A; Balachander S; Fisher K; Webb S; Wood C; DeFazio A; Wilcken N; Gao B; Karapetis CS; Singh M; Collins IM; Richardson G; Steer C; Warren M; Karanth N; Wright G; Williams S; George J; Hicks RJ; Boussioutas A; Gill AJ; Solomon BJ; Xu H; Fellowes A; Fox SB; Schofield P; Bowtell D; Mileshkin L; Tothill RW, 2022, DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primary, http://dx.doi.org/10.1101/2022.06.24.22276729

Back to profile page